GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA
Clinical trials for GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for stomach cancer: experimental drug BHB810 enters human trials
Disease control Not yet recruitingThis study tests a new drug, BHB810, in adults with advanced stomach or gastroesophageal junction cancer that has not responded to standard treatments. The drug is given as an IV infusion every two weeks. The main goals are to check safety, find the best dose, and see if it can s…
Matched conditions: GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: BigHat Biosciences, Inc. • Aim: Disease control
Last updated May 17, 2026 02:18 UTC
-
Blood test may predict stomach cancer return after surgery
Knowledge-focused Not yet recruitingThis study tests whether a simple blood test that looks for tumor DNA (ctDNA) can help doctors decide on the best treatment after surgery for stomach or gastroesophageal junction cancer. About 32 people with stage III or IVA cancer will have their blood checked at several times b…
Matched conditions: GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Knowledge-focused
Last updated May 17, 2026 02:07 UTC